What is the projected market valuation of the Needle-Free Drug Delivery Device Market by 2035?

The projected market valuation is expected to reach 12.91 USD Billion by 2035. Read More

What was the market valuation of the Needle-Free Drug Delivery Device Market in 2024?

The market valuation was 6.82 USD Billion in 2024. Read More

What is the expected CAGR for the Needle-Free Drug Delivery Device Market during the forecast period 2025 - 2035?

The expected CAGR is 5.97% during the forecast period 2025 - 2035. Read More

Which device type segment is projected to have the highest valuation by 2035?

The Jet Injectors segment is projected to reach 2.8 USD Billion by 2035. Read More

What application segment is anticipated to grow the most in the Needle-Free Drug Delivery Device Market?

The Vaccination application segment is anticipated to grow to 4.5 USD Billion by 2035. Read More

Which end-use segment is expected to have the largest market share by 2035?

The Hospitals end-use segment is expected to reach 5.12 USD Billion by 2035. Read More

What technology segment is projected to show significant growth by 2035?

The Thermal Technology segment is projected to grow to 4.61 USD Billion by 2035. Read More

What was the valuation of the Microneedles segment in 2024?

The Microneedles segment was valued at 1.2 USD Billion in 2024. Read More

How does the projected growth of the Pain Management application segment compare to other segments by 2035?

The Pain Management application segment is projected to reach 2.2 USD Billion by 2035, indicating moderate growth compared to others. Read More

What is the expected market size of the Global Needle-Free Drug Delivery Device Market by 2024?

The Global Needle-Free Drug Delivery Device Market is expected to be valued at 6.44 USD Billion by 2024. Read More

What is the projected market size for the Global Needle-Free Drug Delivery Device Market in 2035?

In 2035, the Global Needle-Free Drug Delivery Device Market is anticipated to reach a value of 14.5 USD Billion. Read More

What is the expected CAGR for the Global Needle-Free Drug Delivery Device Market from 2025 to 2035?

The expected CAGR for the Global Needle-Free Drug Delivery Device Market from 2025 to 2035 is 7.66%. Read More

Which region is expected to hold the largest market share in 2024?

North America is expected to hold the largest market share, valued at 2.6 USD Billion in 2024. Read More

What is the estimated value of the Chronic Disease Management segment in 2024?

The Chronic Disease Management application segment is estimated to be valued at 1.55 USD Billion in 2024. Read More

What is the projected market value of the Vaccination application in 2035?

The Vaccination application is projected to reach a market value of 5.75 USD Billion in 2035. Read More

Who are the key players in the Global Needle-Free Drug Delivery Device Market?

Key players include InsuJet, Injex Pharma, OptiNose, and Antares Pharma among others. Read More

What is the forecasted market value for the APAC region by 2035?

The APAC region's market value is forecasted to reach 4.1 USD Billion by 2035. Read More

What is the estimated market size for Insulin Delivery by 2035?

The Insulin Delivery segment is estimated to have a market size of 2.55 USD Billion by 2035. Read More

What challenges might the Global Needle-Free Drug Delivery Device Market face in the forecast period?

Challenges may include regulatory hurdles and market penetration of newer technologies during the forecast period. Read More

Needle-Free Drug Delivery Device Market

Q: Who are the key players in the Needle-Free Drug Delivery Device Market?

Key players include BD, Zynerba Pharmaceuticals, PharmaJet, Injex Pharma, Valeritas, MedImmune, Antares Pharma, and Vaxart. Read More

ID: MRFR/HC/40895-HCR

100 Pages

Rahul Gotadki

Last Updated: April 06, 2026

Needle-Free Drug Delivery Device Market Research Report: Size, Share, Trend Analysis By Device Type (Jet Injectors, Microneedles, Transdermal Patches, Inhalers, Others), By Applications (Vaccination, Chronic Disease Management, Pain Management, Hormone Therapy), By End Use (Hospitals, Home Care Settings, Pharmaceutical Companies, Research Institutions), By Technology (Focused Ultrasound, Electroporation, Pressure-Driven Technology, Thermal Technology) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Needle-Free Drug Delivery Device Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)5.97%

2024 Market Size$ 6.82 Billion

2025 Market Size$ 7.23 Billion

2035 Market Size$ 12.91 Billion

Key Players

Zynerba Pharmaceuticals

PharmaJet

Injex Pharma

Valeritas

MedImmune

Trends

Technological Advancements
Increased Focus on Patient Compliance
Expansion of Applications

Opportunities

Government Initiatives and Support
Rising Incidence of Chronic Diseases
Increased Focus on Patient Compliance

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Device Type (USD Billion)
  1. 4.1.1 Jet Injectors
  2. 4.1.2 Microneedles
  3. 4.1.3 Transdermal Patches
  4. 4.1.4 Inhalers
  5. 4.1.5 Others
2. 4.2 Healthcare, BY Application (USD Billion)
  1. 4.2.1 Vaccination
  2. 4.2.2 Chronic Disease Management
  3. 4.2.3 Pain Management
  4. 4.2.4 Hormone Therapy
3. 4.3 Healthcare, BY End Use (USD Billion)
  1. 4.3.1 Hospitals
  2. 4.3.2 Home Care Settings
  3. 4.3.3 Pharmaceutical Companies
  4. 4.3.4 Research Institutions
4. 4.4 Healthcare, BY Technology (USD Billion)
  1. 4.4.1 Focused Ultrasound
  2. 4.4.2 Electroporation
  3. 4.4.3 Pressure-Driven Technology
  4. 4.4.4 Thermal Technology
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 BD (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Zynerba Pharmaceuticals (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 PharmaJet (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Injex Pharma (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Valeritas (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 MedImmune (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Antares Pharma (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Vaxart (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY DEVICE TYPE
4. 6.4 US MARKET ANALYSIS BY APPLICATION
5. 6.5 US MARKET ANALYSIS BY END USE
6. 6.6 US MARKET ANALYSIS BY TECHNOLOGY
7. 6.7 CANADA MARKET ANALYSIS BY DEVICE TYPE
8. 6.8 CANADA MARKET ANALYSIS BY APPLICATION
9. 6.9 CANADA MARKET ANALYSIS BY END USE
10. 6.10 CANADA MARKET ANALYSIS BY TECHNOLOGY
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY DEVICE TYPE
13. 6.13 GERMANY MARKET ANALYSIS BY APPLICATION
14. 6.14 GERMANY MARKET ANALYSIS BY END USE
15. 6.15 GERMANY MARKET ANALYSIS BY TECHNOLOGY
16. 6.16 UK MARKET ANALYSIS BY DEVICE TYPE
17. 6.17 UK MARKET ANALYSIS BY APPLICATION
18. 6.18 UK MARKET ANALYSIS BY END USE
19. 6.19 UK MARKET ANALYSIS BY TECHNOLOGY
20. 6.20 FRANCE MARKET ANALYSIS BY DEVICE TYPE
21. 6.21 FRANCE MARKET ANALYSIS BY APPLICATION
22. 6.22 FRANCE MARKET ANALYSIS BY END USE
23. 6.23 FRANCE MARKET ANALYSIS BY TECHNOLOGY
24. 6.24 RUSSIA MARKET ANALYSIS BY DEVICE TYPE
25. 6.25 RUSSIA MARKET ANALYSIS BY APPLICATION
26. 6.26 RUSSIA MARKET ANALYSIS BY END USE
27. 6.27 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
28. 6.28 ITALY MARKET ANALYSIS BY DEVICE TYPE
29. 6.29 ITALY MARKET ANALYSIS BY APPLICATION
30. 6.30 ITALY MARKET ANALYSIS BY END USE
31. 6.31 ITALY MARKET ANALYSIS BY TECHNOLOGY
32. 6.32 SPAIN MARKET ANALYSIS BY DEVICE TYPE
33. 6.33 SPAIN MARKET ANALYSIS BY APPLICATION
34. 6.34 SPAIN MARKET ANALYSIS BY END USE
35. 6.35 SPAIN MARKET ANALYSIS BY TECHNOLOGY
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY DEVICE TYPE
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY END USE
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY DEVICE TYPE
42. 6.42 CHINA MARKET ANALYSIS BY APPLICATION
43. 6.43 CHINA MARKET ANALYSIS BY END USE
44. 6.44 CHINA MARKET ANALYSIS BY TECHNOLOGY
45. 6.45 INDIA MARKET ANALYSIS BY DEVICE TYPE
46. 6.46 INDIA MARKET ANALYSIS BY APPLICATION
47. 6.47 INDIA MARKET ANALYSIS BY END USE
48. 6.48 INDIA MARKET ANALYSIS BY TECHNOLOGY
49. 6.49 JAPAN MARKET ANALYSIS BY DEVICE TYPE
50. 6.50 JAPAN MARKET ANALYSIS BY APPLICATION
51. 6.51 JAPAN MARKET ANALYSIS BY END USE
52. 6.52 JAPAN MARKET ANALYSIS BY TECHNOLOGY
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY DEVICE TYPE
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY END USE
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
57. 6.57 MALAYSIA MARKET ANALYSIS BY DEVICE TYPE
58. 6.58 MALAYSIA MARKET ANALYSIS BY APPLICATION
59. 6.59 MALAYSIA MARKET ANALYSIS BY END USE
60. 6.60 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
61. 6.61 THAILAND MARKET ANALYSIS BY DEVICE TYPE
62. 6.62 THAILAND MARKET ANALYSIS BY APPLICATION
63. 6.63 THAILAND MARKET ANALYSIS BY END USE
64. 6.64 THAILAND MARKET ANALYSIS BY TECHNOLOGY
65. 6.65 INDONESIA MARKET ANALYSIS BY DEVICE TYPE
66. 6.66 INDONESIA MARKET ANALYSIS BY APPLICATION
67. 6.67 INDONESIA MARKET ANALYSIS BY END USE
68. 6.68 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
69. 6.69 REST OF APAC MARKET ANALYSIS BY DEVICE TYPE
70. 6.70 REST OF APAC MARKET ANALYSIS BY APPLICATION
71. 6.71 REST OF APAC MARKET ANALYSIS BY END USE
72. 6.72 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY DEVICE TYPE
75. 6.75 BRAZIL MARKET ANALYSIS BY APPLICATION
76. 6.76 BRAZIL MARKET ANALYSIS BY END USE
77. 6.77 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
78. 6.78 MEXICO MARKET ANALYSIS BY DEVICE TYPE
79. 6.79 MEXICO MARKET ANALYSIS BY APPLICATION
80. 6.80 MEXICO MARKET ANALYSIS BY END USE
81. 6.81 MEXICO MARKET ANALYSIS BY TECHNOLOGY
82. 6.82 ARGENTINA MARKET ANALYSIS BY DEVICE TYPE
83. 6.83 ARGENTINA MARKET ANALYSIS BY APPLICATION
84. 6.84 ARGENTINA MARKET ANALYSIS BY END USE
85. 6.85 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY DEVICE TYPE
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY DEVICE TYPE
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY END USE
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY DEVICE TYPE
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY END USE
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
99. 6.99 REST OF MEA MARKET ANALYSIS BY DEVICE TYPE
100. 6.100 REST OF MEA MARKET ANALYSIS BY APPLICATION
101. 6.101 REST OF MEA MARKET ANALYSIS BY END USE
102. 6.102 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY DEVICE TYPE, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY DEVICE TYPE, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY END USE, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.2.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.3.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.3.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.4.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.4.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.5.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.5.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.6.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.6.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.7.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.7.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.8.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.8.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.9.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.9.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.10.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.10.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.11.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.11.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.12.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.12.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.13.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.13.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.14.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.14.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.15.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.15.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.16.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.16.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.17.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.17.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.18.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.18.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.19.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.19.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.20.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.20.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.21.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.21.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.22.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.22.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.23.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.23.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.24.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.24.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.25.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.25.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.26.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.26.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.27.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.27.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.28.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.28.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.29.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.29.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.30.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.30.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Needle-Free Drug Delivery Device Market Segmentation

Needle-Free Drug Delivery Device Market By Device Type (USD Billion, 2025-2035)

Jet Injectors
Microneedles
Transdermal Patches
Inhalers
Others

Needle-Free Drug Delivery Device Market By Application (USD Billion, 2025-2035)

Vaccination
Chronic Disease Management
Pain Management
Hormone Therapy

Needle-Free Drug Delivery Device Market By End Use (USD Billion, 2025-2035)

Hospitals
Home Care Settings
Pharmaceutical Companies
Research Institutions

Needle-Free Drug Delivery Device Market By Technology (USD Billion, 2025-2035)

Focused Ultrasound
Electroporation
Pressure-Driven Technology
Thermal Technology

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”